Related Experiment Videos
Matrix metalloproteinase-9 in peripheral blood eosinophils
1Department of Pediatrics, Mie National Hospital, Mie, Japan.
International Archives of Allergy and Immunology
|October 26, 1999
Summary
Circulating eosinophils contain minimal matrix metalloproteinase-9 (MMP-9). Complex activation signals are likely required for eosinophils to produce significant MMP-9, a key mediator in allergic inflammation.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in tumor invasion and inflammation.
- Eosinophils in asthmatic airways show overexpression of MMP-9 mRNA.
- The role of eosinophils as a source of MMPs in allergic inflammation requires clarification.
Purpose of the Study:
- To quantify matrix metalloproteinase-9 (MMP-9) content in peripheral blood eosinophils.
- To compare MMP-9 levels in eosinophils with other leukocyte populations (neutrophils, mononuclear cells).
- To investigate the potential for eosinophils to produce MMP-9 upon stimulation.
Main Methods:
- Purification of peripheral blood eosinophils, neutrophils, and mononuclear cells using Percoll gradient centrifugation and CD16 negative selection.
- Quantification of MMP-9 in cell lysates and culture supernatants using gelatin zymography and ELISA.
- Stimulation of purified eosinophils with IL-5, PAF, and PMA to assess MMP-9 production.
Main Results:
- Eosinophils contained significantly lower amounts of MMP-9 (2.5 ng/5x10^6 cells) compared to neutrophils (4,073 ng/5x10^6 cells).
- MMP-9 content in eosinophils did not differ between normal donors and asthma patients.
- IL-5 stimulation did not induce MMP-9 production in eosinophils; PMA and other secretogogues resulted in minimal MMP-9 secretion.
Conclusions:
- Circulating eosinophils possess only small intrinsic amounts of MMP-9.
- Eosinophils may require complex activation pathways to generate MMP-9 levels observed in allergic inflammation tissues.
- These findings suggest eosinophils are not a primary source of MMP-9 in circulation but may contribute under specific inflammatory conditions.